Literature DB >> 11719520

Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.

James W Furbee1, Janet K Sawyer, John S Parks.   

Abstract

The purpose of the present study was to test the hypothesis that lecithin:cholesterol acyltransferase (LCAT) deficiency would accelerate atherosclerosis development in low density lipoprotein (LDL) receptor (LDLr-/-) and apoE (apoE-/-) knockout mice. After 16 weeks of atherogenic diet (0.1% cholesterol, 10% calories from palm oil) consumption, LDLr-/- LCAT-/- double knockout mice, compared with LDLr-/- mice, had similar plasma concentrations of free (FC), esterified (EC), and apoB lipoprotein cholesterol, increased plasma concentrations of phospholipid and triglyceride, decreased HDL cholesterol, and 2-fold more aortic FC (142 +/- 28 versus 61 +/- 20 mg/g protein) and EC (102 +/- 27 versus 61+/- 27 mg/g). ApoE-/- LCAT-/- mice fed the atherogenic diet, compared with apoE-/- mice, had higher concentrations of plasma FC, EC, apoB lipoprotein cholesterol, and phospholipid, and significantly more aortic FC (149 +/- 62 versus 109 +/- 33 mg/g) and EC (101 +/- 23 versus 69 +/- 20 mg/g) than did the apoE-/- mice. LCAT deficiency resulted in a 12-fold increase in the ratio of saturated + monounsaturated to polyunsaturated cholesteryl esters in apoB lipoproteins in LDLr-/- mice and a 3-fold increase in the apoE-/- mice compared with their counterparts with active LCAT. We conclude that LCAT deficiency in LDLr-/- and apoE-/- mice fed an atherogenic diet resulted in increased aortic cholesterol deposition, likely due to a reduction in plasma HDL, an increased saturation of cholesteryl esters in apoB lipoproteins and, in the apoE-/- background, an increased plasma concentration of apoB lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719520     DOI: 10.1074/jbc.M109883200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

2.  Electrospray MS/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions.

Authors:  Patrick M Hutchins; Ernest E Moore; Robert C Murphy
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

3.  Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.

Authors:  Hiroyuki Tanigawa; Jeffrey T Billheimer; Jun-ichiro Tohyama; Ilia V Fuki; Dominic S Ng; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

Review 4.  HDL-targeted therapies: progress, failures and future.

Authors:  Bronwyn A Kingwell; M John Chapman; Anatol Kontush; Norman E Miller
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

5.  Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation.

Authors:  Qiang Cao; Xianfeng Wang; Lin Jia; Ashis K Mondal; Abdoulaye Diallo; Gregory A Hawkins; Swapan K Das; John S Parks; Liqing Yu; Huidong Shi; Hang Shi; Bingzhong Xue
Journal:  Endocrinology       Date:  2014-09-24       Impact factor: 4.736

6.  The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic mice.

Authors:  I Zanotti; C Maugeais; M Pedrelli; M Gomaraschi; P Salgam; L Calabresi; F Bernini; H Kempen
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

7.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

Authors:  Jenelle M Timmins; Ji-Young Lee; Elena Boudyguina; Kimberly D Kluckman; Liam R Brunham; Anny Mulya; Abraham K Gebre; Jonathan M Coutinho; Perry L Colvin; Thomas L Smith; Michael R Hayden; Nobuyo Maeda; John S Parks
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

Review 8.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

9.  Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.

Authors:  Manal Zabalawi; Shaila Bhat; Tara Loughlin; Michael J Thomas; Eric Alexander; Mark Cline; Bill Bullock; Mark Willingham; Mary G Sorci-Thomas
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence.

Authors:  Yun-Hee Youm; Thirumala-Devi Kanneganti; Bolormaa Vandanmagsar; Xuewei Zhu; Anthony Ravussin; Ayinuer Adijiang; John S Owen; Michael J Thomas; Joseph Francis; John S Parks; Vishwa Deep Dixit
Journal:  Cell Rep       Date:  2012-01-26       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.